• Publications
  • Influence
Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.
Cardiac remodeling is generally accepted as a determinant of the clinical course of heart failure (HF). Defined as genome expression resulting in molecular, cellular and interstitial changes andExpand
  • 2,007
  • 59
  • PDF
Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.
OBJECTIVES The purpose of this study was to determine the effect of amino-terminal pro-brain natriuretic peptide (N-BNP) on the diagnostic accuracy of heart failure (HF) in primary care. BACKGROUNDExpand
  • 249
  • 14
Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON)
The association between sympathetic activation and mortality in chronic heart failure and the favorable effect of beta blocking drugs has raised the possibility of therapeutic efficacy for centralExpand
  • 300
  • 13
Uptake of self‐management strategies in a heart failure management programme
Multidisciplinary heart failure programs including patient education and self‐management strategies such as daily recording of body weight and use of a patient diary decrease hospital readmissionsExpand
  • 158
  • 12
Does a glass of red wine improve endothelial function?
AIMS To examine the acute effect of red wine and de-alcoholized red wine on endothelial function. METHODS AND RESULTS High frequency ultrasound was used to measure blood flow and percentageExpand
  • 211
  • 11
  • PDF
Factors influencing the length of hospital stay of patients with heart failure
Heart failure (HF) is characterised by frequent hospital admissions and prolonged length of hospital stay. Admissions for HF have increased over the last decade while length of stay has decreased;Expand
  • 108
  • 11
Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group.
OBJECTIVES The primary objective of this study was to investigate the effects of the angiotensin-converting enzyme (ACE) inhibitor, ramipril, on carotid atherosclerosis in patients with coronary,Expand
  • 231
  • 9
  • PDF
Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study.
AIMS To determine the effect of an integrated heart failure management programme, involving patient and family, primary and secondary care, on quality of life and death or hospital readmissions inExpand
  • 250
  • 7
  • PDF
Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
BACKGROUND Statins inhibit the same biochemical pathway as aminobisphosphonates, therefore these cholesterol-lowering agents may have a beneficial effect on osteoporosis. This possibility has beenExpand
  • 111
  • 6
How low can it go? Projecting ischaemic heart disease mortality in New Zealand to 2015.
AIMS This study aims to identify how ischaemic heart disease (IHD) mortality rates in New Zealand have varied between successive cohorts and time periods. This information is then used to project IHDExpand
  • 63
  • 5